CN1055002C - External-use cream for treatment of breast cancer - Google Patents
External-use cream for treatment of breast cancer Download PDFInfo
- Publication number
- CN1055002C CN1055002C CN96120688A CN96120688A CN1055002C CN 1055002 C CN1055002 C CN 1055002C CN 96120688 A CN96120688 A CN 96120688A CN 96120688 A CN96120688 A CN 96120688A CN 1055002 C CN1055002 C CN 1055002C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- external
- treatment
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010006187 Breast cancer Diseases 0.000 title claims abstract description 20
- 208000026310 Breast neoplasm Diseases 0.000 title claims abstract description 20
- 238000011282 treatment Methods 0.000 title claims abstract description 20
- 239000006071 cream Substances 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 42
- 239000002994 raw material Substances 0.000 claims abstract description 13
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 12
- 244000022198 Mirabilis jalapa Species 0.000 claims abstract description 12
- 235000009053 Mirabilis jalapa Nutrition 0.000 claims abstract description 12
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 8
- 201000008275 breast carcinoma Diseases 0.000 claims description 13
- 239000010238 camphora Substances 0.000 claims description 11
- 229940025250 camphora Drugs 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 241000195474 Sargassum Species 0.000 claims description 8
- 201000011510 cancer Diseases 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 13
- 201000000849 skin cancer Diseases 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract description 3
- 208000000453 Skin Neoplasms Diseases 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000723346 Cinnamomum camphora Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 240000005729 Cylindropuntia imbricata Species 0.000 abstract 1
- 235000001427 Cylindropuntia imbricata Nutrition 0.000 abstract 1
- 241001466453 Laminaria Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 241000123725 Sophora tonkinensis Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 229960000846 camphor Drugs 0.000 abstract 1
- 229930008380 camphor Natural products 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- -1 common prism rhizome Substances 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 239000011505 plaster Substances 0.000 description 9
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000002574 poison Substances 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 208000025085 carcinoma of parotid gland Diseases 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000009146 rhinoscleroma Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000219470 Mirabilis Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000010759 hypertrophy of breast Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an external-use tumor resisting cream of Chinese patent medicine for treating breast cancer. The existing oral or external-use medicine for treating breast cancer in Chinese traditional treatment has the disadvantages of larger side effect, larger stimulation and no obvious therapeutic effect. The external-use tumor resisting cream of the present invention is prepared from 19 kinds of raw materials of traditional Chinese medicine of milk vetch, weeping forsythiae capsule, common prism rhizome, zedoary, saffron, mirabilis jalapa, cholla stem, curcuma root, blackberrykiky rhizome, dahurian angelica, phellodendron, oldenlandia diffusa, kakuda figwort root, laminaria, alga, lycii radices, mongolian dandelion herb, vietnamese sophora root, camphor, etc. to be prepared into the external-use cream for treating breast cancer. The present invention has the advantages of small side effect and stimulation, the clinical efficiency reaches 92.3%, and other tumors and lumps of superficial skin cancer can be treated.
Description
The invention belongs to a kind of external Chinese patent medicine for the treatment of breast carcinoma.
Breast carcinoma is one of women's common cancer, about 20,/10 ten thousand people of the sickness rate of China's breast carcinoma, and the whole nation has 20,000 women dead because of suffering from breast cancer every year approximately.Modern medicine thinks that this disease and ovarian hormone level, the factors such as biography, virus, contact lonizing radiation and dietary habit of sending are relevant.The traditional Chinese medical science thinks that primary disease is to belong to " breast carcinoma " category, is because internal injury caused by excess of seven emotions, the QI and blood disorder, zang-fu disharmony causes in the evil poison and invades, the stasis of blood Ruzhong that stagnates, with the passing of time except that and cause.Doctor trained in Western medicine has measures such as operation, radiotherapy, medicine and immunotherapy to the treatment of primary disease.The tradition traditional Chinese medical science adopts internal treatments such as soothing liver-QI for relieving depression, dispersing swelling and dissipating binds, benefiting QI and nourishing blood then according to dialectical.Folk prescription, the proved recipe that external treatment are also arranged more among the people, but toxic and side effects that has and zest are big, and the effect that has is imprecise.
The present invention aim to provide a kind of toxic and side effects and zest little, the external Chinese patent medicine of eutherapeutic treatment breast carcinoma.
For achieving the above object, the present invention is the external Chinese patent medicine of being made by the following weight Chinese medicinal raw materials (b is Unit Weight part)
Radix Astragali 50-70b Fructus Forsythiae 40-60b rhizoma sparganic 20-30b Rhizoma Curcumae 20-30b
Stigma Croci 7-13b Mirabilis jalapa 50-70b Radix et Caulis Opuntiae Dillenii 50-70b Radix Curcumae 17-23b
Rhizoma Belamcandae 15-21b Radix Angelicae Dahuricae 25-35b Cortex Phellodendri 25-35b Hedyotidis Diffusae 17-23b
Radix Scrophulariae 20-30b Thallus Laminariae (Thallus Eckloniae) 25-35b Sargassum 25-35b Cortex Lycii 25-35b
Herba Taraxaci 35-55b Radix Sophorae Tonkinensis 25-35b Camphora 4-6b
The raw material of Chinese medicine of said ratio is made the externally applied ointment dosage form.
The formula optimization weight proportion of preparation medicine of the present invention is:
Radix Astragali 60b Fructus Forsythiae 50b rhizoma sparganic 25b Rhizoma Curcumae 25b
Stigma Croci 10b Mirabilis jalapa 60b Radix et Caulis Opuntiae Dillenii 60b Radix Curcumae 20b
Rhizoma Belamcandae 18b Radix Angelicae Dahuricae 30b Cortex Phellodendri 30b Hedyotidis Diffusae 20b
Radix Scrophulariae 25b Thallus Laminariae (Thallus Eckloniae) 30b Sargassum 30b Cortex Lycii 30b
Herba Taraxaci 45b Radix Sophorae Tonkinensis 30b Camphora 5b
It is considered herein that breast carcinoma system is owing to endexoteric is assorted to causing a disease.It is relevant that endogenous cause of ill and human righteousness lack of proper care, and exopathogenic factor then is to invade in the evil poison, causes the internal resistance of stasis of blood poison, the stasis of blood Ruzhong that stagnates.Therefore the principles of formulating prescriptions of this medicine are: strengthening vital QI to eliminate pathogenic factors, heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, the dehumidifying of invigorating blood circulation.This treatment policy meets the occurrence regularity of primary disease, and treating both the principal and secondary aspects of a disease is the fundamental cause that this medicine is obtained better curative effect.
The product of the Radix Astragali for tonifying Qi of the kidney can improve the health immunologic function in the side, and the adjustable body endocrine of giving sb. a hard time of modern pharmacy research is with strong points to the treatment of mastopathy, excellent to the repair ability of ulcer wound in addition, and the eliminating blood stasis to promote regeneration of blood effect is arranged.
All the other 18 flavor raw material of Chinese medicine divide three major types:
Antipyretic and antidotal type: Fructus Forsythiae, Mirabilis jalapa, Radix et Caulis Opuntiae Dillenii, Radix Scrophulariae, Rhizoma Belamcandae, Cortex Phellodendri, Hedyotidis Diffusae, Herba Taraxaci, Radix Sophorae Tonkinensis, Cortex Lycii.Wherein Mirabilis jalapa (Mirabilis jalapal.) nature and flavor are sweet, cool, are used for the treatment of inclined to one side peach body inflammation clinically more, and the anti-inflammation and sterilization function is arranged, and the present invention finds that its dermal osmosis power is very strong, and Fang Zhongjia can improve curative effect greatly with this medicine, and this is one of this plaster characteristic.
The dehumidifying class of invigorating blood circulation: Stigma Croci, Radix Curcumae, the Radix Angelicae Dahuricae, Camphora.Stigma Croci wherein has the effect of the body local of elimination lump through modern pharmacological research, and Camphora is the dermal osmosis medicine, can promote the absorption of skin to medicine, and exsiccation is arranged.
Medicinal powder for relieving pain knot class: rhizoma sparganic, Rhizoma Curcumae, Thallus Laminariae (Thallus Eckloniae), Sargassum.Wherein rhizoma sparganic, Rhizoma Curcumae compatibility are the product of the medicinal powder for relieving pain knot commonly used, Thallus Laminariae (Thallus Eckloniae), iodine-containing seaweed, algae propylhomoserin and polysaccharide etc., and the pain that disappears effect is significantly.
Administrated method: earlier illing skin is cleaned, with 0.1-0.2% rivanoli solution skin degerming, plaster is heated again, be affixed on disease sites after softening, changed dressings once in 5-7 days, drug withdrawal is four hours during changing dressings for twice, and medication one month was a course of treatment.In the time of this medicine of external, also can adopt traditional Chinese medical discrimination method to take corresponding decoction Chinese medicine according to patient's different clinical symptoms to the patient, take the spleen invigorating decoction as the cooperation of appetite difference, charthartic is taken in the cooperation of constipation, and the weak cooperation of health is taken and set upright drugs strengthening spleen etc.
For many years, this medicine is used to treat breast tumor and carcinoma of parotid gland, parotitis and the hundreds of examples of various skin cancer, receives different treatment effects, is the 26 routine breast carcinoma of complete data and the therapeutic effect statistics of 58 routine cyclomastopathy below
| Kinds of Diseases | The example number | Clinical recovery | Take a turn for the better | Invalid | |||
| Example | ％ | Example | ％ | Example | ％ | ||
| Breast carcinoma | 26 | 3 | 11.5 | 21 | 80.8 | 2 | 7.7 |
| Cyclomastopathy | 58 | 39 | 67.2 | 16 | 27.6 | 3 | 5.2 |
More than add up as can be known, this medicine is 92.3% to the breast cancer treatment total effective rate, and the clinical recovery rate is 11.5%; To the cyclomastopathy total effective rate is 94.8%, and the clinical recovery rate reaches 67.2%.And the person that finds no the toxicity.
Model case
Example 1 Wang Lan English, woman, 67 years old, Hong Quan people from building, Linfen, Shanxi Province.Be diagnosed as breast carcinoma in local hospital in March, 94, makes resection operation at once, finds that lump appears shifting about 3.8cm * 3.8cm in the mammary gland position in November, 95 again, and scleroma appears again in the neck lymph, and pain is obvious.Come the court with the external application of this medicine at the beginning of 96 years 1 month, because of patient's desire that holds a sinecure poor, so cooperate one pair of spleen invigorating decoction for oral administration every day, this plaster changed once in 7 days, medication only 15 days, mammary gland tumor and lymph scleroma are eliminated substantially, clinical symptoms is improved, and pain disappears, and appetite takes a turn for the better, obtained clinical recovery, followed up a case by regular visits to and do not recur half a year.
Example 2 merchants like duckweed, woman, 33 years old, Ningwu County, Shanxi Province middle school teacher, find the bilateral breast hypertrophy at the beginning of 93, about 6.5cm * 6.5cm size has at ordinary times and painfully feels, though obey multiple in, Western medicine, DeGrain is in March, 95 the court's treatment, with the external application of this plaster, changed dressings once in 8 days, logotype 50 days, therebetween because of the patient with menoxenia, give the regulating menstruation Chinese medicine decoction simultaneously, all eliminate to both sides cyclomastopathy between in May, 95, pain disappears, all diseases are all removed, further consultation at the beginning of 96, efficacy consolidation.
This plaster is clinical for many years to be used for hundreds of routine breast carcinoma patients, obtains unusual promising result, and can doublely control other superficial part skin cancerous protuberance and lump, as carcinoma of parotid gland, cyclomastopathy, parotitis and skin carcinoma etc., all receives certain effect.Do not act on intensive insects medicine in this prescription, so the property of medicine is comparatively steady, skin is had no stimulation, safe and reliable, toxic and side effects is little, and easy to use, and the patient is easy to accept.
Embodiment 1
This example is the patent medicine that adopts following Chinese medicine raw materials by weight proportion to make:
Radix Astragali 60g Fructus Forsythiae 50g rhizoma sparganic 25g Rhizoma Curcumae 25g
Stigma Croci 10g Mirabilis jalapa 60g Radix et Caulis Opuntiae Dillenii 60g Radix Curcumae 20g
Rhizoma Belamcandae 18g Radix Angelicae Dahuricae 30g Cortex Phellodendri 30g Hedyotidis Diffusae 20g
Radix Scrophulariae 25g Thallus Laminariae (Thallus Eckloniae) 30g Sargassum 30g Cortex Lycii 30g
Herba Taraxaci 45g Radix Sophorae Tonkinensis 30g Camphora 5g
The raw material of Chinese medicine of said ratio is made the plaster dosage form, and concrete method for making is:
Remove Mirabilis jalapa, Radix et Caulis Opuntiae Dillenii, outside the Camphora, it is standby earlier all the other 16 flavor raw materials to be processed into coarse powder, again an amount of Oleum sesami (Oleum sesami is about 1.2: 1 with the ratio of raw material of Chinese medicine gross weight) is burnt heat in pot, the coarse powder of 16 flavor medicines are dropped into soak after 24 hours reheat in the oil once, heating is three times continuously, medical material promptly becomes dark brown, take out medicinal residues then, continue heating, put into the Plumbum preparatium fine powder of oil mass 30%-40% simultaneously, again with the Radix et Caulis Opuntiae Dillenii of mashing, Mirabilis jalapa adds, fully stir, keep about 70 ℃ of temperature, at last in the ointment that Camphora is processed, on the cloth that the stand is applied to 15 15cm is sticked one piece of cloth or paper on top of another plaster.
Embodiment 2
This example is the plaster (b is Unit Weight part) that adopts following Chinese medicine raw materials by weight proportion to make:
Radix Astragali 55b Fructus Forsythiae 45b rhizoma sparganic 20b Rhizoma Curcumae 22b
Stigma Croci 8b Mirabilis jalapa 55b Radix et Caulis Opuntiae Dillenii 55b Radix Curcumae 18b
Rhizoma Belamcandae 16b Radix Angelicae Dahuricae 25b Cortex Phellodendri 25b Hedyotidis Diffusae 18b
Radix Scrophulariae 20b Thallus Laminariae (Thallus Eckloniae) 25b Sargassum 25b Cortex Lycii 25b
Herba Taraxaci 40b Radix Sophorae Tonkinensis 25b Camphora 4b
Embodiment 3
This example is the plaster that adopts following Chinese medicine raw materials by weight proportion to make:
Radix Astragali 65b Fructus Forsythiae 55b rhizoma sparganic 30b Rhizoma Curcumae 30b
Stigma Croci 12b Mirabilis jalapa 65b Radix et Caulis Opuntiae Dillenii 65b Radix Curcumae 22b
Rhizoma Belamcandae 20b Radix Angelicae Dahuricae 35b Cortex Phellodendri 35b Hedyotidis Diffusae 22b
Radix Scrophulariae 30b Thallus Laminariae (Thallus Eckloniae) 35b Sargassum 35b Cortex Lycii 35b
Herba Taraxaci 50b Radix Sophorae Tonkinensis 35b Camphora 6b
Claims (2)
1, the external Chinese patent medicine cream for treatment of cancer of treatment breast carcinoma, it is characterized in that: this medicine is to make (b is Unit Weight part) by the following weight Chinese medicinal raw materials:
Radix Astragali 50-70b Fructus Forsythiae 40-60b rhizoma sparganic 20-30b Rhizoma Curcumae 20-30b
Stigma Croci 7-13b Mirabilis jalapa 50-70b Radix et Caulis Opuntiae Dillenii 50-70b Radix Curcumae 17-23b
Rhizoma Belamcandae 15-21b Radix Angelicae Dahuricae 25-35b Cortex Phellodendri 25-35b Hedyotidis Diffusae 17-23b
Radix Scrophulariae 20-30b Thallus Laminariae (Thallus Eckloniae) 25-35b Sargassum 25-35b Cortex Lycii 25-35b
Herba Taraxaci 35-55b Radix Sophorae Tonkinensis 25-35b Camphora 4-6b
Above-mentioned Chinese medicine raw materials by weight proportion is made the externally applied ointment dosage form.
2, the external Chinese patent medicine cream for treatment of cancer of treatment breast carcinoma according to claim 1 is characterized in that, this medicine is to be made by the following weight Chinese medicinal raw materials:
Radix Astragali 60b Fructus Forsythiae 50b rhizoma sparganic 25b Rhizoma Curcumae 25b
Stigma Croci 10b Mirabilis jalapa 60b Radix et Caulis Opuntiae Dillenii 60b Radix Curcumae 20b
Rhizoma Belamcandae 18b Radix Angelicae Dahuricae 30b Cortex Phellodendri 30b Hedyotidis Diffusae 20b
Radix Scrophulariae 25b Thallus Laminariae (Thallus Eckloniae) 30b Sargassum 30b Cortex Lycii 30b
Herba Taraxaci 45b Radix Sophorae Tonkinensis 30b Camphora 5b
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96120688A CN1055002C (en) | 1996-11-21 | 1996-11-21 | External-use cream for treatment of breast cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96120688A CN1055002C (en) | 1996-11-21 | 1996-11-21 | External-use cream for treatment of breast cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1158262A CN1158262A (en) | 1997-09-03 |
| CN1055002C true CN1055002C (en) | 2000-08-02 |
Family
ID=5126511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96120688A Expired - Fee Related CN1055002C (en) | 1996-11-21 | 1996-11-21 | External-use cream for treatment of breast cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1055002C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1294920C (en) * | 2002-08-06 | 2007-01-17 | 刘卫国 | Medicine prepared with cactus and taraxacum and its prepn. process |
| CN100350933C (en) * | 2003-07-15 | 2007-11-28 | 何清源 | Externally applied medicament for treating mammary gland disease and its preparing method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129122A (en) * | 1995-02-13 | 1996-08-21 | 张驰 | Ruan decoction for treatment of heperplasia of mamary glands and mamary ache |
-
1996
- 1996-11-21 CN CN96120688A patent/CN1055002C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129122A (en) * | 1995-02-13 | 1996-08-21 | 张驰 | Ruan decoction for treatment of heperplasia of mamary glands and mamary ache |
Non-Patent Citations (1)
| Title |
|---|
| 河北中医1987,9(5) 1987.1.1 刘建德，清解汤治疗癌有效 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1158262A (en) | 1997-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101816736B (en) | Chinese medicament capsule for curing nasosinusitis | |
| CN102008610B (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN104383445A (en) | Traumatic injury analgesic | |
| CN100386106C (en) | Medicine for treating acne and its preparation | |
| CN103495126A (en) | Traditional Chinese medicine composition treating rheumatism | |
| CN1055002C (en) | External-use cream for treatment of breast cancer | |
| CN1201765C (en) | Chinese medicine ointment for treating arthrosis | |
| CN114028507A (en) | Preparation method of traditional Chinese medicine for treating lumbago | |
| CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
| CN1181879C (en) | Analgestic plaster | |
| CN1410093A (en) | Medicine for treating cyst | |
| CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
| CN104887970A (en) | Acupuncture and moxibustion physiotherapy ointment for external use | |
| CN1058189C (en) | External- and thermal-mounted trauma medicinal powder bag | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN101297937B (en) | Chinese patent medicine preparation for treating cervical spondylosis and preparation method thereof | |
| CN112057555B (en) | A composition for treating keratotic skin diseases and its preparation method | |
| CN101983681A (en) | Medicament for treating abnormal leucorrhea | |
| CN100335079C (en) | Oral Chinese medicine preparation of caput femoris ischemic necrosis and production thereof | |
| CN1404850A (en) | Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine | |
| CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
| CN1413599A (en) | Capsule for removing obstruction inchannels to removing blood stasis and its making method | |
| CN106853193A (en) | It is a kind of to treat Chinese medicine of rheumatoid arthritis and preparation method thereof | |
| CN105833074A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN105327290A (en) | Traditional Chinese medicine for external use for treating diabetic gangrene and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |